Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Share Issue/Capital Change 2019

Dec 17, 2019

5262_rns_2019-12-17_0bd31222-307d-4a37-8886-294259bc2bdf.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1322X

GlaxoSmithKline PLC

17 December 2019

GlaxoSmithKline plc

Blocklisting Application

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 370,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.

The Shares are being reserved under an existing blocklisting and will be issued under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan.

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.

Admission is expected to be effective on 18 December 2019.

Victoria Whyte

Company Secretary

17 December 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSLIFSTFLLDLIA